van Gijn W, van de Velde C J H
Department of Surgery, Leiden University Medical Center, The Netherlands.
Acta Chir Iugosl. 2010;57(3):17-21. doi: 10.2298/aci1003017v.
In recent years there have been significant improvements in outcome of rectal cancer treatment. Both new surgical techniques as well as effective neoadjuvant treatment regimens have contributed to these improvements. It is key to spread these advances towards every rectal cancer patient and to make sure that not only patients who are treated within the framework of clinical trials may benefit from these advancements. Throughout Europe there have been interesting quality programs that have proved to facilitate the spread of up to date knowledge and skills among medical professionals resulting in improved treatment outcome. Nevertheless, between European countries remain differences in outcome and treatment schedules that cannot be easily explained. The European CanCer Organisation (ECCO) has recognised these importances's and created the 'European Registration of Cancer Care' (EURECCA) framework to develop a European colorectal audit structure. EURECCA will advance future treatment improvements and spread these to all European cancer patients. It provides opportunities to treat elderly and comorbid patients evidence based while it offers an unique insight in social-economical healthcare matters. As such, ECCO has established the basis for a strong, multidisciplinary audit structure with the commitment to improve cancer care for every European cancer patient.
近年来，直肠癌的治疗效果有了显著改善。新的手术技术和有效的新辅助治疗方案都促成了这些改善。关键在于将这些进展推广到每一位直肠癌患者，并确保不仅是在临床试验框架内接受治疗的患者能从这些进步中受益。在整个欧洲，有一些有趣的质量项目已证明有助于在医学专业人员中传播最新的知识和技能，从而改善治疗效果。然而，欧洲国家之间在治疗效果和治疗方案上仍存在难以轻易解释的差异。欧洲癌症组织（ECCO）已经认识到这些重要性，并创建了“欧洲癌症护理登记”（EURECCA）框架，以建立一个欧洲结直肠癌审计结构。EURECCA将推动未来治疗的改进，并将这些改进推广到所有欧洲癌症患者。它为基于证据治疗老年和合并症患者提供了机会，同时在社会经济医疗问题方面提供了独特的见解。因此，ECCO已经为一个强大的多学科审计结构奠定了基础，致力于改善每一位欧洲癌症患者的癌症护理。
